1 completed, 1 not yet recruiting, 1 recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow RiMO-301: new trials by email Literature Review of RiMO-301 trials Research Report on RiMO-301
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RiMO-HNC-NEO1: Phase 2 Study of RiMO-301 and Hypofractionated Radiotherapy With Pembrolizumab for the Neoadjuvant Treatment of Resectable, Locally Advanced Head-Neck Cancer RiMO-301, Pembrolizumab, Radiation - Head and Neck Cancer, Head Cancer | Phase 2 | Not yet recruiting | University of Illinois at Chicago | 20 | 2026-08-01 | 2026-07-29 |
| Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer RiMO-301 - Head Neck Cancer, Intratumoral Injection | Phase 1 / Phase 2 | Recruiting | Coordination Pharmaceuticals, Inc. | 16 | 2023-04-03 | 2025-09-17 |
| Phase I Study of RiMO-301 With Radiation in Advanced Tumors RiMO-301 - Advanced Tumors | Phase 1 | Completed | Coordination Pharmaceuticals, Inc. | 32 | 2018-04-10 | 2025-09-15 |
Coordination Pharmaceuticals, Inc. (2) · University of Illinois at Chicago (1)
United States (3)